Skip to main content
. 2020 Oct 28;12(1):111–120. doi: 10.1007/s12687-020-00490-4

Table 2.

Chemoprevention recommendation by specialist for women at high or moderate risk of familial breast cancer (FBC)

Recommendation of chemoprevention by participating services, n (%)
Yes No
By FBC risk
  High risk, n = 50 40 (80) 10 (20)
  Moderate, n = 49 31 (63) 18 (37)
Combination of responses, n = 50 N (%)
  Yes for high and moderate risk 29 (58)
  Yes for high risk, no for moderate risk 11 (22)
  No for high risk, yes for moderate risk 2 (4)
  No for high and moderate risk 7 (14)
  No for high, no entry for moderate risk 1 (2)
High risk, n = 50
  Responses by specialty
    Breast 31 (78) 9 (23)
    Genetics 9 (90) 1 (10)
  Responses by health care role
    Doctor 26 (90) 3 (10)
      Physician 18 (90) 2 (10)
      Surgeon 8 (89) 1 (11)
    Nurse 13 (68) 6 (32)
    Others* 1 (50) 1 (50)
Moderate risk, n = 49
  Responses by specialty
    Breast 23 (59) 16 (41)
    Genetics 8 (80) 2 (20)
  Responses by health care role
    Doctor 20 (69) 9 (31)
      Physician 14 (70) 6 (30)
      Surgeon 6 (67) 3 (33)
    Nurse 11 (61) 7 (39)
    Others* 0 2 (100)

*Others include clinical manager and radiographer